S

SDGR

SDGR

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
SDGR Live QuoteReal-time
$26.34
+$2.44(+10.21%)1M
Day Range$26.27 – $28.56
Open$27.56
Previous Close$27.20
Volume1.45M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$1.98B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-0.79
Price to Book6.8
Dividend Yield0.65%
Beta (Volatility)1.65
IndustryHEALTH INFORMATION SERVICES
52-Week RangeCurrent: $26.34 (67%)
Low: $10.95High: $34.00
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$33.57-77.6% upside

Insider Buys

0

$0

Insider Sales

25

$4.05M

Total Volume

$4.05M

25 transactions

Net Activity

$4.05M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
A
1

Akinsanya Karen

See Remarks

0 buys3 sells

$1.37M total

T
2

Tran Yvonne

EVP, CLO, CPO

0 buys5 sells

$1.21M total

F
3

Farid Ramy

Pres, CEO

0 buys2 sells

$1.10M total

P
4

Porges Geoffrey Craig

EVP, CFO

0 buys1 sells

$119K total

A
5

Abel Robert Lorne

See Remarks

0 buys3 sells

$65K total

Trading History
SDGR insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 9, 2026

1 weeks ago

Tran Yvonne

EVP, CLO, CPO

EVP
Sell32.0K$32.85$1.05M

Sep 17, 2026

2 months ago

Akinsanya Karen

See Remarks

Insider
Sell31.6K$29.37$928K

Jul 16, 2026

4 months ago

Jain Rachit

EVP, CFO

CFO
Sell875$15.60$14K

Apr 16, 2026

7 months ago

Farid Ramy

Pres, CEO

CEO
Sell86.0K$12.27$1.06M

Apr 16, 2026

7 months ago

Jain Rachit

EVP, CFO

CFO
Sell844$12.75$11K

Mar 5, 2026

8 months ago

Herman Jenny

CAO

Insider
Sell1.4K$12.84$18K

Mar 5, 2026

8 months ago

Jain Rachit

EVP, CFO

CFO
Sell1.6K$12.90$21K

Mar 5, 2026

8 months ago

Tran Yvonne

EVP, CLO, CPO

EVP
Sell1.1K$12.90$14K

Mar 5, 2026

8 months ago

Farid Ramy

Pres, CEO

CEO
Sell3.7K$12.91$47K

Mar 5, 2026

8 months ago

Akinsanya Karen

See Remarks

Insider
Sell1.4K$12.90$18K

Mar 5, 2026

8 months ago

Lorton Kenneth Patrick

EVP, CTO, COO, Software

COO
Sell1.2K$12.90$16K

Mar 4, 2026

8 months ago

Abel Robert Lorne

See Remarks

Insider
Sell1.3K$12.81$17K

Feb 10, 2026

9 months ago

Tran Yvonne

EVP, CLO, CPO

EVP
Sell776$13.80$11K

Feb 10, 2026

9 months ago

Lorton Kenneth Patrick

EVP, CTO, COO, Software

COO
Sell925$13.73$13K

Feb 10, 2026

9 months ago

Herman Jenny

CAO

Insider
Sell752$13.79$10K

Feb 9, 2026

9 months ago

Abel Robert Lorne

See Remarks

Insider
Sell1.2K$13.51$17K

Oct 16, 2025

13 months ago

Dugan Margaret

Chief Medical Officer

C-Level
Sell1.4K$21.07$29K

Apr 14, 2025

19 months ago

Akinsanya Karen

Pres of R, D, Therapeutics

President
Sell16.7K$25.09$420K

Mar 6, 2025

20 months ago

Herman Jenny

SVP, Controller

SVP
Sell666$21.11$14K

Mar 3, 2025

20 months ago

Porges Geoffrey Craig

EVP, CFO

CFO
Sell5.5K$21.76$119K

Feb 18, 2025

21 months ago

Tran Yvonne

EVP, CLO, CPO

EVP
Sell3.9K$28.00$109K

Feb 10, 2025

21 months ago

Abel Robert Lorne

See Remarks

Insider
Sell1.2K$25.99$32K

Feb 11, 2025

21 months ago

Lorton Kenneth Patrick

EVP, CTO, COO, Software

COO
Sell985$24.43$24K

Feb 11, 2025

21 months ago

Herman Jenny

SVP, Controller

SVP
Sell859$24.43$21K

Feb 11, 2025

21 months ago

Tran Yvonne

EVP, CLO, CPO

EVP
Sell828$24.43$20K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
SDGR Buy Conviction0%
Industry Rank#338 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

SDGR has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. SDGR ranks #338 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for SDGR

Over the last 90 days, corporate insiders at SDGR (SDGR) engaged in a total of 25 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 25 were sales. The total volume of insider trading reached $4.05M.

The net insider activity for SDGR shows a net selling bias of $4.05M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Farid Ramy (Pres, CEO), who traded 86.0K shares valued at $1.06M on Apr 16, 2026.

Live Market News & Developments
Aggregated real-time headlines for SDGR (SDGR)
6 updates

Schrödinger (SDGR) Stock Could Be Undervalued On Its 67% Run

Yahoo Finance5d ago

SDGR Stock: Schrödinger Hopes Its AI Agent Can Transform Drug Discovery

CMC Markets49d ago

Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline

Yahoo Finance23d ago

Schrödinger: The Software Business Is Stronger Than It Looks (NASDAQ:SDGR)

Seeking Alpha91d ago

Schrödinger (SDGR) Stock Could Be 30% Undervalued Following Bunsen AI Progress

Simply Wall St13d ago

Schrodinger Inc. (SDGR) Stock Falls on Q4 2025 Earnings

Quiver Quantitative267d ago

FAQs About SDGR Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for SDGR.

Based on SEC Form 4 disclosures, the Insider Confidence Score for SDGR is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 25 sales by company executives over the last 90 days.

The CEO Conviction Index for SDGR is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.